{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T22:59:54Z","timestamp":1777417194899,"version":"3.51.4"},"reference-count":100,"publisher":"Informa UK Limited","issue":"3","funder":[{"name":"No funding"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Investigational Drugs"],"published-print":{"date-parts":[[2024,3,3]]},"DOI":"10.1080\/13543784.2024.2323528","type":"journal-article","created":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T16:34:42Z","timestamp":1708706082000},"page":"279-285","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":7,"title":["A modest proposal: targeting \u03b1v integrin-mediated activation of latent TGFbeta as a novel therapeutic approach to treat scleroderma fibrosis"],"prefix":"10.1080","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2832-283X","authenticated-orcid":false,"given":"Andrew","family":"Leask","sequence":"first","affiliation":[{"name":"University of Saskatchewan","place":["Saskatoon, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asmaa","family":"Fadl","sequence":"additional","affiliation":[{"name":"University of Saskatchewan","place":["Saskatoon, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angha","family":"Naik","sequence":"additional","affiliation":[{"name":"University of Saskatchewan","place":["Saskatoon, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2024,2,26]]},"reference":[{"issue":"11","key":"e_1_3_4_3_1","first-page":"4776","article-title":"Synergistic interaction of two classes of transforming growth factors from murine sarcoma cells","volume":"42","author":"Anzano MA","year":"1982","unstructured":"Anzano MA, Roberts AB, Meyers CA, et al. Synergistic interaction of two classes of transforming growth factors from murine sarcoma cells. Cancer Res. 1982 Nov;42(11):4776\u20134778.","journal-title":"Cancer Res"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.80.12.3676"},{"issue":"4","key":"e_1_3_4_5_1","first-page":"683","article-title":"Transforming growth factors","volume":"4","author":"Roberts AB","year":"1985","unstructured":"Roberts AB, Sporn MB. Transforming growth factors. Cancer Surv. 1985;4(4):683\u2013705.","journal-title":"Cancer Surv"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1524-475X.1995.t01-1-30314.x"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.3109\/08977199109000293"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.2442813"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)68822-2"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.85.13.4894"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj2470597"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3468(88)80638-9"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.83.12.4167"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00205600"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.168.2.737"},{"key":"e_1_3_4_16_1","first-page":"259","article-title":"Transforming growth factor-beta and suppression of carcinogenesis","volume":"20","author":"Sporn MB","year":"1989","unstructured":"Sporn MB, Roberts AB, Wakefield LM, et al. Transforming growth factor-beta and suppression of carcinogenesis. Princess Takamatsu Symp. 1989;20:259\u2013266.","journal-title":"Princess Takamatsu Symp"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V72.5.1504.1504"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1357-2725(96)00121-5"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1359-6101(97)00010-5"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar1976"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.2302\/kjm.53.74"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M208544200"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M210366200"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1359-6101(99)00026-X"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrm3434"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aav5183"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.3109\/08977199009037500"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.106.5.1659"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcb.2008.01.012"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.matbio.2015.05.006"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/37284"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-437X(98)80069-5"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.03-1273rev"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcdb.2019.11.013"},{"issue":"4","key":"e_1_3_4_35_1","first-page":"628","article-title":"Involvement of extracellular signal-regulated kinase 2 and stress-activated protein kinase\/Jun N-terminal kinase activation by transforming growth factor beta in the negative growth control of breast cancer cells","volume":"57","author":"Frey RS","year":"1997","unstructured":"Frey RS, Mulder KM. Involvement of extracellular signal-regulated kinase 2 and stress-activated protein kinase\/Jun N-terminal kinase activation by transforming growth factor beta in the negative growth control of breast cancer cells. Cancer Res. 1997 Feb 15;57(4):628\u201333.","journal-title":"Cancer Res"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M100754200"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M102382200"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M010149200"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrm809"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.25879"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0218178"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.24223"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0186740"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12079-020-00596-x"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.30074"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.38121"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201800622RR"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2017.03.029"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2020020190"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-017-1356-3"},{"issue":"1","key":"e_1_3_4_51_1","first-page":"115","article-title":"Signaling in fibrosis: targeting the TGFbeta, endothelin-1 and CCN2 axis in scleroderma frontiers in bioscience","volume":"1","author":"Leask A","year":"2009","unstructured":"Leask A. Signaling in fibrosis: targeting the TGFbeta, endothelin-1 and CCN2 axis in scleroderma frontiers in bioscience. Elite. 2009;1 E(1):115\u2013122.","journal-title":"Elite"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.2326-5205.1989.tb00012.x"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780330507"},{"issue":"2","key":"e_1_3_4_54_1","first-page":"241","article-title":"Fibronectin release by systemic sclerosis and normal dermal fibroblasts in response to TGF-beta","volume":"18","author":"Xu WD","year":"1991","unstructured":"Xu WD, Leroy EC, Smith EA. Fibronectin release by systemic sclerosis and normal dermal fibroblasts in response to TGF-beta. J Rheumatol. 1991 Feb;18(2):241\u2013246.","journal-title":"J Rheumatol"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12495664"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(05)81456-1"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/0923-1811(92)90026-8"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.51.3.362"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780370218"},{"issue":"6","key":"e_1_3_4_60_1","first-page":"885","article-title":"Collagen type I is not under autocrine control by transforming growth factor-beta 1 in normal and scleroderma fibroblasts","volume":"71","author":"McWhirter A","year":"1994","unstructured":"McWhirter A, Colosetti P, Rubin K, et al. Collagen type I is not under autocrine control by transforming growth factor-beta 1 in normal and scleroderma fibroblasts. Lab Invest. 1994 Dec;71(6):885\u2013894.","journal-title":"Lab Invest"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-857X(05)70294-5"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0923-1811(99)00008-0"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.275.20.15220"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2008.080382"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200405-612OC"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.01048.2009"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5001775"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1002\/path.2870"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2006.12.003"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab580"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.21725"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5700303"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kes234"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.1111\/wrr.12889"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.22289"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI77958"},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80545-0"},{"key":"e_1_3_4_78_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.24801"},{"key":"e_1_3_4_79_1","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.070672"},{"key":"e_1_3_4_80_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3282"},{"key":"e_1_3_4_81_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12079-014-0221-2"},{"key":"e_1_3_4_82_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.175.11.7708"},{"key":"e_1_3_4_83_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.21246"},{"key":"e_1_3_4_84_1","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2006.041306"},{"key":"e_1_3_4_85_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5700331"},{"key":"e_1_3_4_86_1","unstructured":"[cited 2024 Jan 29]. Available from: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Bexotegrast"},{"key":"e_1_3_4_87_1","unstructured":"[cited 2023 Nov 1]. Available from: https:\/\/pliantrx.com\/pln-74809\/"},{"key":"e_1_3_4_88_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-023-01032-1"},{"key":"e_1_3_4_89_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-021-00284-4"},{"key":"e_1_3_4_90_1","doi-asserted-by":"publisher","DOI":"10.2174\/1871520618666181119103413"},{"key":"e_1_3_4_91_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-81253-0"},{"key":"e_1_3_4_92_1","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.354"},{"issue":"9","key":"e_1_3_4_93_1","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1136\/ard-2023-223859","article-title":"Tripterygium wilfordii derivative celastrol, a YAP inhibitor, has antifibrotic effects in systemic sclerosis","volume":"82","author":"Chitturi P","year":"2023","unstructured":"Chitturi P, Xu S, Ahmed Abdi B, et al. Tripterygium wilfordii derivative celastrol, a YAP inhibitor, has antifibrotic effects in systemic sclerosis. Ann Rheum Dis. 2023 Sep;82(9):1191\u20131204.","journal-title":"Ann Rheum Dis"},{"key":"e_1_3_4_94_1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2011.156"},{"key":"e_1_3_4_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2019.03.027"},{"key":"e_1_3_4_96_1","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.12060"},{"key":"e_1_3_4_97_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-224129"},{"key":"e_1_3_4_98_1","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2012-0050OC"},{"key":"e_1_3_4_99_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab075"},{"key":"e_1_3_4_100_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-00436-9"},{"key":"e_1_3_4_101_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4652(199910)181:1<153::AID-JCP16>3.0.CO;2-K"},{"key":"e_1_3_4_102_1","doi-asserted-by":"publisher","DOI":"10.1038\/d41573-022-00135-w"}],"container-title":["Expert Opinion on Investigational Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543784.2024.2323528","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T07:08:57Z","timestamp":1738220937000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543784.2024.2323528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,26]]},"references-count":100,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3,3]]}},"alternative-id":["10.1080\/13543784.2024.2323528"],"URL":"https:\/\/doi.org\/10.1080\/13543784.2024.2323528","relation":{},"ISSN":["1354-3784","1744-7658"],"issn-type":[{"value":"1354-3784","type":"print"},{"value":"1744-7658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,26]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-11-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}